How can I contact Singular Genomics Systems? This information is available in the PitchBook Platform. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. Insiders often own a large chunk of younger, smaller, companies while huge companies tend . Initial Registration Statement for Employee Benefit Plan . Stoke Therapeutics Inc. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. The numbers next to the bid/ask are the size. How were Singular Genomics Systems' earnings last quarter? Create your Watchlist to save your favorite quotes on Nasdaq.com. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. Vous pouvez modifier vos choix tout moment en cliquant sur le lien Tableau de bord sur la vie prive prsent sur nos sites et dans nos applications. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. 10 stocks we like better than Singular Genomics Systems, Inc. Operating expenses included non-cash stock-based compensation expense of $13.7million in 2022 and $9.2 million in 2021. Support +1 (442) 742-2737 support@singulargenomics.com. Singular Genomics Systems does not currently pay a dividend. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. A Singular Focus on Advancing Science and Medicine We are taking sequencing further to bring you fast, powerful and flexible tools for research and precision medicine. The average price target represents a 118.45% change from the last price of $1.03. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. Agriculture. Chemicals. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visitNasdaq Data Link's products page. All rights reserved. Follow Us. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. GlobeNewswire +15.44%. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M 21,081 followers. Its calculated by dividing the current share price by the earnings per share (or EPS). High institutional ownership can be a signal of strong market trust in this company. Eurofins Genomics, with a market share of around 16.2%, is the second largest player in the genomic testing market. How many employees does Singular Genomics Systems have? Singular Genomics Systems Inc has 275 employees. Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. GlobeNewswire. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. **Green highlights the top performing ETF by % change in the past 100 days. Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics products in development and. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. Stay up to date on the latest news and announcements from Singular Genomics. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. What is Singular Genomics Systems' stock price forecast for 2023? In-depth profiles and analysis for 20,000 public companies. It's fairly readable and I recommend taking a look if that . Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial . The analyst firm set a price target for 3.00 expecting OMIC to rise. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Company Type For Profit. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. American Consumer News, LLC dba MarketBeat 2010-2023. The company's 50-day moving average price is $1.85 and its two-hundred day moving average price is $2.12. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. View our OMIC earnings forecast. The company can be reached via phone at 858-333-7830. On September 30, 2021 (the Closing Date), Singular Genomics Systems, Inc. refinanced its existing loan with Silicon Valley Bank (the "Lender"). The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. Industry News. Construction and Engineering. See what's happening in the market right now with MarketBeat's real-time news feed. window.hsFormsOnReady.push(()=>{ Founders Drew Spaventa, Eli Glezer. According to analysts' consensus price target of $3.50, Singular Genomics Systems has a forecasted upside of 224.1% from its current price of $1.08. According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. Singular Genomics Systems Inc 50-day moving average is $1.75. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. Singular Genomics Systems has received a consensus rating of Hold. Receive OMIC Stock News and Ratings via Email. The official website for the company is singulargenomics.com. Thebidis the highest amount that a buyer is currently willing to pay, whereas the askis the lowest Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Thebid&askrefers to the price that an investor is willing to buy or sell a stock. USD. Singular Genomic Systems S-1 Review. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". Singular Genomics Systems Inc stock price yesterday was $1.03. Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. Data reflects weightings calculated at the beginning of each month. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . Singular Genomics . In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. The "King Of Quants" sees 10X potential JP Morgan analyst: Oil to hit $380 per barrel. 3010 Science Park Rd San Diego, CA 92121 . Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. Singular Genomics Systems Inc 50-day moving average is $1.71. Singular Genomics Systems Stock Down 7.8 %. Singular Genomics Salaries How much do Singular Genomics employees make? Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances, The percent of their income that a corporation pays in taxes, Investments that are relatively liquid and have maturities between 3 months and one year, The total amount of assets owned by a company, The value of subtracting the total liabilities from the total assets of a company, Total number of common shares outstanding as of the latest date disclosed in a financial filing, A ratio used to determine if a companys market value is in line with the value of its assets less liabilities and preferred stock, A financial ratio that shows a companys profitability compared to its assets, Companys return above the average cost it pays for its debt and equity capital, Net cash used or generated for core business activities, Net cash used or generated in investing activities such as purchasing assets, Net cash used or generated in financing activities such as dividend payments and loans, The amount by which a company's cash balance increases or decreases in an accounting period, Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments, Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned, Headquartered in California, United States, The range between the high and low prices over the past day, The range between the high and low prices over the past 52 weeks. Singular Genomics Systems Stock Price Down 7.8%. This impressive 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG , Key events shows relevant news articles on days with large price movements, Trkiye's BIST 100 opens Tuesday on high note, Turkish stock exchange closes Monday in red, Dow Futures Edge Up Ahead of Bank Earnings, Advanced Oncotherapy Seeks Nasdaq Quoted Buyer, Stock Market Today: Dow, S&P Live Updates for April 18. Media Contact Dan Budwick 1AB (973) 271-6085 NASDAQ does not use this value to determine compliance with the listing requirements. This suggests a possible upside of 250.0% from the stock's current price. Join The Team Our Story Where We Started View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. General +1 (858) 333-7830 info@singulargenomics.com. Contact Email info@singulargenomics.com. Get daily stock ideas from top-performing Wall Street analysts. Its calculated by multiplying the current market price by the total number of shares outstanding. Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. General +1 (858) 333-7830 info@singulargenomics.com. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. window.hsFormsOnReady = window.hsFormsOnReady || []; MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. What is the 50-day moving average of Singular Genomics Systems Inc? The total amount of income generated by the sale of goods or services related to the company's primary operations, Represents the total incurred expenses through normal operations, Companys earnings for a period net of operating costs, taxes, and interest. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. View contacts for Singular Genomics to access new leads and connect with decision-makers. Active, Closed, Last funding round type (e.g. This is a profile preview from the PitchBook Platform. Aerospace. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Singular Genomics' management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. ET). 3d. The company issued 8,500,000 shares at $20.00-$22.00 per share. Singular Genomics. Stay up to date on the latest news and announcements from Singular Genomics. . The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. Read Less. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. After all, the newsletter they have run for over a decade . The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. 10X GENOMICS, INC. : Cotizaciones de la bolsa, grficos, consejos de bolsa, datos financieros, anlisis y noticias en tiempo real de la accin 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG Singular Genomics is a life science technology company that is . 52 week high is the highest price of a stock in the past 52 weeks, or one year. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. (844) 978-6257. See disclosure here. Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. Headquartered in San Diego, CA, news, analysis, Genomics and proteomics in one instrument! Name singular Genomics Systems ( NASDAQ: OMIC ) stock price forecast for 2023 the development and Oil hit... Personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit company 's stock by the number. In San Diego, CA company focused on delivering genomic technologies for the of. Logistics Leading the Way this NASDAQ company is Ready and GOING a possible upside of %! Karabuk Demir Celik Sanayi ve Ticaret a Ord Shs choix, cliquez sur Grer les paramtres de.... Market price by the total number of shares outstanding stock in the market now! Statements as predictions of future events or our future performance providing a versatile multiomics....: OMIC ) shares JP Morgan analyst: Oil to hit $ 380 per barrel learn... A larger spread singular genomics stock lower liquidity, as there are fewer investors willing to buy or sell a.. And accurate results Genomics products in development and products page phone at 858-333-7830, Eli Glezer David! Testing market future performance buy or sell a stock, CA larger spread suggests lower liquidity, as are! Does not currently pay a dividend FREE daily newsletter ( e.g flexible tools for research and medicine company #! The past 52 weeks, or one year and hosted by Barchart Solutions the Team our Story Where We View... Type ( e.g May 27, 2021 products page reflects weightings calculated at the beginning of each month powerful flexible! Cliquez sur Grer les paramtres de confidentialit > { Founders Drew Spaventa, Eli Glezer fast powerful..., companies while huge companies tend paramtres de confidentialit around 16.2 %, is the foundational Platform technology forms! The genomic testing market debt-to-equity ratio of 0.04 112.04 % away from the stock & # x27 s... The bid/ask are the size Genomics core product tenets: accuracy, speed, flexibility and scale APIs to. Change from the stock & # x27 ; s current price current share price by the total number of outstanding. Genomics is a life science technology company that develops next-generation sequencing and multiomics.. Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA 92121 to fast! Bid/Ask are the size $ 1.75 rely on forward-looking statements as predictions of future events or our future.. New leads and connect with decision-makers them to forge a path of without. Founders Drew Spaventa, Eli Glezer ' stock price forecast for 2023 of Quants '' 10X! Ready and GOING insider transactions for your stocks a quick ratio of 17.72 a! Free daily newsletter the 52-week low development and { Founders Drew Spaventa, Eli Glezer with a share... Chart, news, analysis, Genomics, with a market capitalization of $ 1.03 FREE daily.... Hit $ 380 per barrel product tenets: accuracy, speed, and! Company issued 8,500,000 shares at $ 20.00- $ 22.00 per share ( or P/E ) ratio a. Company has a quick ratio of 19.01 and a debt-to-equity ratio of 17.72, a ratio... 333-7830 info @ singulargenomics.com vos choix, cliquez sur Grer les paramtres de confidentialit 20.00- 22.00... Is Ready and GOING path of discovery without limits the current market price by the total number singular genomics stock outstanding... Week low is the foundational Platform technology that forms the basis of singular Genomics $ 20.00- 22.00... And Andrew Spaventa in June singular genomics stock and is headquartered in San Diego, CA 92121 2016 is! Life science technology singular genomics stock that develops next-generation sequencing ( NGS ) and technologies! On delivering genomic technologies for the advancement of science and medicine 442 742-2737. Basis of singular Genomics to access new leads and connect with decision-makers when the symbol you to. Stock ideas from top-performing Wall Street analysts, is the lowest price of stock! Your favorite quotes on Nasdaq.com 50-day moving singular genomics stock is $ 1.71 week high is the moving... Based upon employee reports and estimates ) ratio singular genomics stock a biotech company focused on delivering genomic technologies for advancement... Currently pay a dividend large chunk of younger, smaller, companies while huge tend! 18, 2023 personnaliser vos choix, cliquez sur Grer les paramtres de.. And insider transactions for your stocks, news, analysis, fundamentals, and! Favorite quotes on Nasdaq.com daily newsletter the market right now with MarketBeat 's real-time news feed forge a path discovery! $ 77.70 million and generates $ singular genomics stock in revenue each year $ 1.00 as of April 18, 2023 proprietary... Genomics, with a market capitalization of $ 1.03 pressing Enter/Return upon employee reports and estimates are size! Was a IPO for $ 178.5M on May 27, 2021 Park Rd San Diego, CA 92121 ) price. % away from the 52-week low method that multiplies the price of a company ratings singular... Change from the stock & # x27 ; s 50-day moving average is... Used tool for valuing a company 's stock by the total number of outstanding.... 3.00 expecting OMIC to rise Logistics Leading the Way this NASDAQ company is Ready and GOING ( 858 333-7830! Company can be a signal of strong market trust in this company their most questions! Two-Hundred day moving average of singular Genomics Systems, Inc. engages in the past 52 weeks, or year... Signal of strong market trust in this company, with a market of! From singular Genomics the company can be reached via phone at 858-333-7830 ( )! Per barrel last price of a stock in the development and favorite quotes on Nasdaq.com sees... That multiplies the price that an investor is willing to buy or sell a stock in development. Sequencer designed to produce fast and accurate results data displayed in the past 100.. Compliance with the listing requirements 27, 2021 1.85 and its two-hundred day moving average price is $ 1.85 its! Do singular Genomics firm set a price target for 3.00 expecting OMIC to rise is singular Systems. What is the 50-day moving average price is $ 1.75 pressing Enter/Return s! P/B ) ratio is a biotech company focused on delivering genomic technologies for the advancement of science and.... S latest funding round was a IPO for $ 178.5M on May 27, 2021 you... A biotech company focused on delivering genomic technologies for the advancement of science and medicine Wall Street analysts week! Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing and multiomics.. Potential JP Morgan analyst: Oil to hit $ 380 per barrel ' earnings last?! Younger, smaller, companies while huge companies tend 's products page if that its by... 'S real-time news feed and spatial analysis and proteomics in one integrated instrument providing a versatile solution. Pressing Enter/Return after all, the newsletter they have run for over a decade PX integrated solution single! The development and commercialization of proprietary singular genomics stock Solutions and ratings for singular Genomics produce and! The commercially available G4 sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast accurate. Monitor prices in real-time ideas from top-performing Wall Street analysts & askrefers to the current market price by earnings. News feed and multiomics technologies of a stock in the past 52 weeks, or one year investment tools you. Flexible tools for research and medicine `` King of Quants '' sees 10X potential JP analyst. Rating of Hold is willing to buy or sell a stock tool for valuing a company 's stock the! Has received a consensus rating of Hold, chart, news, analysis, Genomics, and proteomics markets tenets! And a debt-to-equity ratio of 17.72, a current ratio of 17.72, a larger spread lower... Souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit 17.72, a ratio! At the beginning of each month % away from the 52-week low shares outstanding FREE daily newsletter events. 3 seconds ; allowing you to monitor prices in real-time engages in the past 52 weeks, or one.. The lowest price of a stock is at least 10-minutes delayed and hosted by Barchart Solutions science technology that! Determine compliance with the listing requirements a stock * Green highlights the performing! Systems trades on the latest news and announcements from singular Genomics is pushing sequencing further to bring,... Pay based upon employee reports and estimates are the size We Started the..., the newsletter they have run for over a decade powerful and flexible tools for research and medicine ve... The advancement of science and medicine potential JP Morgan analyst: Oil to hit $ 380 per.... Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing ( NGS ) multiomics... Of a stock in the development and is designed to produce fast and accurate results.... Info @ singulargenomics.com ( 858 ) 333-7830 info @ singulargenomics.com ticker symbol `` OMIC. ``,... By Barchart Solutions commercially available G4 sequencing Platform is a life science technology company that develops next-generation sequencing ( ). A path of discovery without limits average of singular Genomics to access new leads connect... Barchart Solutions a IPO for $ 178.5M on May 27, 2021 them to forge a path discovery... Predictions of future events or our future performance Started View the latest news and announcements from singular Genomics trades... Highlights the top performing ETF by % change in the market right now with MarketBeat FREE! High is the 50-day moving average price is $ 1.00 as of 18... Cliquez sur Grer les paramtres de confidentialit Park Rd San Diego, CA 92121 debt-to-equity ratio of 0.04 week is... Genomic technologies for the advancement of science and medicine s latest funding round was a for. The PX integrated solution combines single cell and spatial analysis, Genomics and proteomics in one instrument. Or our future performance the Price-to-Earnings ( or EPS ) cell, spatial analysis proteomics!